Moyamoya disease associated with antiphospholipid syndrome

Moyamoya (MMD) is a disease that often involves the vascular structures of anterior cerebral circulation, particularly the proximal segments of anterior and middle cerebral arteries. The etiology of the disease is unknown. MMD often presents with cerebral ischemia and rarely with cerebral hemorrhage. The pathology is termed Moyamoya syndrome (MMS) when the pathological cerebral angiography findings are accompanied by meningitis, neurofibromatosis, neoplasm, Down syndrome or polycystic kidney disease. Autoimmune diseases including Graves’ disease, Behcet’s disease and antiphospholipid syndrome might also lead to the development of MMS. In this manuscript, we presented an interesting case of MMD associated with antiphospholipid syndrome, which is quite a rare cause of acute cerebral infarction in childhoo

Comparison of max vo2 levels of elite and deaf footballers

The aim of this study is to determine the endurance performance of the players of the hearing handicapped football team and compare it with those professional players in the same age group playing in Turkish 1st and 3rd leagues For this purpose the players of teams in the Turkish first and the third divisions and the Turkish national hearing handicapped football team who won the world championship in 2012 were subjected to shuttle run and their maximum speeds, hearth rates, and maximum oxygen consumption rates (max VO2) were determine. At the end of the study all these three parameters of the hearing handicapped team were found to be lower with a statistically significance extent than the values obtained from the two professional teams(p<0.01) This can be attributed to selection of the players of the handicapped team from a much smaller group of players , the lack of training and competitions and they were forced to work in different jobs due the fact that the economic income they obtained from the sport was not sufficient enough

Maternal and Fetal Outcomes Among Pregnant Women with Immune Thrombocytopenic Purpura

OBJECTIVE: We aimed to report six pregnant women with immune thrombocytopenic purpura (ITP) followed and delivered at our clinic. STUDY DESIGN: This retrospective study was concluded at Dicle University, School of Medicine, Department of Obstetrics and Gynecology, between January 2008 and December 2008. The cases with ITP were referred from the outside centers to our clinic. RESULTS: The mean platelet count of the cases were 70.9 K/UL (18.1-107). The mean age of the cases were 29.4 (20-39), gravidy 3.6 (1-7), and parity 2.6 (0-6). The cases had ITP diagnose before pregnancy, 4 (66.6 %) of the cases had term pregnancy and spontaneous labor, 2 (33.4%) preeclampsia and preterm labor. We induced the labor of these two cases with preeclampsia and delivered vaginally. The other 3 cases had also delivered vaginally, but one of the cases had fetal distress during labor and had cesarean delivery. The babies were healthy, with mean birth weight of 2810 g (1900-3100), 1 minute Apgar score 5 (3-7) and 5 minute 6.6 (5-9). We had transfused 1 unite of trombocyst apheresis solution to one of the case. The cases discharged from the hospital without any complication and day 2-4 days (2.8 days). CONCLUSION: ITP in pregnancy can be a complex and a challenging disease. Mothers with ITP require monitoring during pregnancy and may require intervention with agents to raise the platelet count. With a multidisciplinary approach including obstetrician, hematologist and pediatrician good outcomes can be taken for mother and fetus